IBDEI06Y ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,2935,1,3,0)
 ;;=3^Hemorrhage,Nontraumatic Subdural,Unspec
 ;;^UTILITY(U,$J,358.3,2935,1,4,0)
 ;;=4^I62.00
 ;;^UTILITY(U,$J,358.3,2935,2)
 ;;=^5007289
 ;;^UTILITY(U,$J,358.3,2936,0)
 ;;=R58.^^18^210^34
 ;;^UTILITY(U,$J,358.3,2936,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2936,1,3,0)
 ;;=3^Hemorrhage NEC
 ;;^UTILITY(U,$J,358.3,2936,1,4,0)
 ;;=4^R58.
 ;;^UTILITY(U,$J,358.3,2936,2)
 ;;=^5019528
 ;;^UTILITY(U,$J,358.3,2937,0)
 ;;=E78.0^^18^210^40
 ;;^UTILITY(U,$J,358.3,2937,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2937,1,3,0)
 ;;=3^Hypercholesterolemia,Pure
 ;;^UTILITY(U,$J,358.3,2937,1,4,0)
 ;;=4^E78.0
 ;;^UTILITY(U,$J,358.3,2937,2)
 ;;=^5002966
 ;;^UTILITY(U,$J,358.3,2938,0)
 ;;=E78.1^^18^210^41
 ;;^UTILITY(U,$J,358.3,2938,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2938,1,3,0)
 ;;=3^Hyperglyceridemia,Pure
 ;;^UTILITY(U,$J,358.3,2938,1,4,0)
 ;;=4^E78.1
 ;;^UTILITY(U,$J,358.3,2938,2)
 ;;=^101303
 ;;^UTILITY(U,$J,358.3,2939,0)
 ;;=E78.2^^18^210^42
 ;;^UTILITY(U,$J,358.3,2939,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2939,1,3,0)
 ;;=3^Hyperlipidemia,Mixed
 ;;^UTILITY(U,$J,358.3,2939,1,4,0)
 ;;=4^E78.2
 ;;^UTILITY(U,$J,358.3,2939,2)
 ;;=^78424
 ;;^UTILITY(U,$J,358.3,2940,0)
 ;;=E78.5^^18^210^43
 ;;^UTILITY(U,$J,358.3,2940,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2940,1,3,0)
 ;;=3^Hyperlipidemia,Unspec
 ;;^UTILITY(U,$J,358.3,2940,1,4,0)
 ;;=4^E78.5
 ;;^UTILITY(U,$J,358.3,2940,2)
 ;;=^5002969
 ;;^UTILITY(U,$J,358.3,2941,0)
 ;;=I10.^^18^210^44
 ;;^UTILITY(U,$J,358.3,2941,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2941,1,3,0)
 ;;=3^Hypertension,Essential
 ;;^UTILITY(U,$J,358.3,2941,1,4,0)
 ;;=4^I10.
 ;;^UTILITY(U,$J,358.3,2941,2)
 ;;=^5007062
 ;;^UTILITY(U,$J,358.3,2942,0)
 ;;=I15.8^^18^210^46
 ;;^UTILITY(U,$J,358.3,2942,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2942,1,3,0)
 ;;=3^Hypertension,Secondary
 ;;^UTILITY(U,$J,358.3,2942,1,4,0)
 ;;=4^I15.8
 ;;^UTILITY(U,$J,358.3,2942,2)
 ;;=^5007074
 ;;^UTILITY(U,$J,358.3,2943,0)
 ;;=I15.0^^18^210^45
 ;;^UTILITY(U,$J,358.3,2943,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2943,1,3,0)
 ;;=3^Hypertension,Renovascular
 ;;^UTILITY(U,$J,358.3,2943,1,4,0)
 ;;=4^I15.0
 ;;^UTILITY(U,$J,358.3,2943,2)
 ;;=^5007071
 ;;^UTILITY(U,$J,358.3,2944,0)
 ;;=I95.1^^18^210^47
 ;;^UTILITY(U,$J,358.3,2944,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2944,1,3,0)
 ;;=3^Hypotension,Orthostatic
 ;;^UTILITY(U,$J,358.3,2944,1,4,0)
 ;;=4^I95.1
 ;;^UTILITY(U,$J,358.3,2944,2)
 ;;=^60741
 ;;^UTILITY(U,$J,358.3,2945,0)
 ;;=I95.89^^18^210^48
 ;;^UTILITY(U,$J,358.3,2945,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2945,1,3,0)
 ;;=3^Hypotension,Other
 ;;^UTILITY(U,$J,358.3,2945,1,4,0)
 ;;=4^I95.89
 ;;^UTILITY(U,$J,358.3,2945,2)
 ;;=^5008079
 ;;^UTILITY(U,$J,358.3,2946,0)
 ;;=I25.9^^18^210^49
 ;;^UTILITY(U,$J,358.3,2946,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2946,1,3,0)
 ;;=3^Ischemic Heart Disease,Chronic,Unspec
 ;;^UTILITY(U,$J,358.3,2946,1,4,0)
 ;;=4^I25.9
 ;;^UTILITY(U,$J,358.3,2946,2)
 ;;=^5007144
 ;;^UTILITY(U,$J,358.3,2947,0)
 ;;=I89.0^^18^210^50
 ;;^UTILITY(U,$J,358.3,2947,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2947,1,3,0)
 ;;=3^Lymphedema NEC
 ;;^UTILITY(U,$J,358.3,2947,1,4,0)
 ;;=4^I89.0
 ;;^UTILITY(U,$J,358.3,2947,2)
 ;;=^5008073
 ;;^UTILITY(U,$J,358.3,2948,0)
 ;;=R01.1^^18^210^51
 ;;^UTILITY(U,$J,358.3,2948,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2948,1,3,0)
 ;;=3^Murmur,Cardia,Unspec
 ;;^UTILITY(U,$J,358.3,2948,1,4,0)
 ;;=4^R01.1
 ;;^UTILITY(U,$J,358.3,2948,2)
 ;;=^5019169
 ;;^UTILITY(U,$J,358.3,2949,0)
 ;;=I21.3^^18^210^52
 ;;^UTILITY(U,$J,358.3,2949,1,0)
 ;;=^358.31IA^4^2
